Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and Temozolomide in Relapsed PCNSL
NCT01985451Phase 2Unknown
- Start
- Mar 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pemetrexed, temozolomide in primary central nervous system lymphoma (PCNSL). Status: unknown.
02
Drugs
pemetrexedtemozolomide
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT01985451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01985451.